GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Level Bio AB (XSAT:LEVBIO) » Definitions » EV-to-EBITDA

Level Bio AB (XSAT:LEVBIO) EV-to-EBITDA : -1.89 (As of May. 18, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Level Bio AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Level Bio AB's enterprise value is kr17.77 Mil. Level Bio AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was kr-9.39 Mil. Therefore, Level Bio AB's EV-to-EBITDA for today is -1.89.

The historical rank and industry rank for Level Bio AB's EV-to-EBITDA or its related term are showing as below:

XSAT:LEVBIO' s EV-to-EBITDA Range Over the Past 10 Years
Min: -274.5   Med: 29.49   Max: 226.34
Current: -1.9

During the past 13 years, the highest EV-to-EBITDA of Level Bio AB was 226.34. The lowest was -274.50. And the median was 29.49.

XSAT:LEVBIO's EV-to-EBITDA is ranked worse than
100% of 112 companies
in the Medical Diagnostics & Research industry
Industry Median: 16.545 vs XSAT:LEVBIO: -1.90

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-18), Level Bio AB's stock price is kr0.32. Level Bio AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.187. Therefore, Level Bio AB's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Level Bio AB EV-to-EBITDA Historical Data

The historical data trend for Level Bio AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Bio AB EV-to-EBITDA Chart

Level Bio AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -31.52 38.00 24.24 -274.23 -3.12

Level Bio AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.42 -17.88 -9.71 -3.12 -1.71

Competitive Comparison of Level Bio AB's EV-to-EBITDA

For the Diagnostics & Research subindustry, Level Bio AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Level Bio AB's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Level Bio AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Level Bio AB's EV-to-EBITDA falls into.



Level Bio AB EV-to-EBITDA Calculation

Level Bio AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=17.765/-9.393
=-1.89

Level Bio AB's current Enterprise Value is kr17.77 Mil.
Level Bio AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-9.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Level Bio AB  (XSAT:LEVBIO) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Level Bio AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.32/-0.187
=At Loss

Level Bio AB's share price for today is kr0.32.
Level Bio AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.187.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Level Bio AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Level Bio AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Level Bio AB (XSAT:LEVBIO) Business Description

Traded in Other Exchanges
N/A
Address
Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30
AlphaHelix Molecular Diagnostics AB develops, manufactures, and markets products for DNA-identification and quantitation in molecular diagnostics and life science research. Its product inlcude Rob, BugScreener MRSA, and aAmp. The company applications inlcude Diagnostics, PCR and Liquid handling.

Level Bio AB (XSAT:LEVBIO) Headlines

No Headlines